About Kinnate Biopharma (KNTE)
Kinnate Biopharma Inc. is a biopharmaceutical company focused on the discovery and development of small molecule kinase inhibitors for difficult-to-treat, genomically defined cancers. The Company utilizes its deep specialization in structure-based dr... Read more
- USD3.73
- USD4.33
- USD3.69
- USD15.86
- 60.10%
- --
- 838.38k
- 174M
- 2.32
- -54.50%
Stock News
Unlock More Stock Analysis & Reports
Access to easy in-depth stock analysis and reports from Refinitiv with analyst estimates on share price movements.
